Insulinoma surgery: Difference between revisions
Jump to navigation
Jump to search
| Line 24: | Line 24: | ||
:*[[Octreotide]] administration | :*[[Octreotide]] administration | ||
:*Continous glucose monitoring | :*Continous glucose monitoring | ||
:* | :*Radiofrequecy ablation | ||
:*[[Embolization]] | :*[[Embolization]] | ||
:*Intra-arterial chemotherapy | :*Intra-arterial chemotherapy | ||
Revision as of 21:34, 7 October 2015
|
Insulinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Insulinoma surgery On the Web |
|
American Roentgen Ray Society Images of Insulinoma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Surgery is the mainstay of treatment for insulinoma. The feasibility of surgery depends on the stage of insulinoma at diagnosis.[1][2]
Surgery
Surgery is the mainstay of treatment for insulinoma. The feasibility of surgery depends on the stage of insulinoma at diagnosis.
Benign Tumors
- Surgical resection is treatment of choice (minimal invasive surgery)
- Enucleation
- Partial pancreatectomy
- Middle pancreatectomy
- Multiple, unencapsulated, >4 cm in diameter, and involves or is near the main pancreatic duct:
- Radical resection
Malignant Tumors
- Aggressive surgical resection, including extended pancreatic resection, liver resection, and/or liver transplantation
- Post-surgical chemoembolization or radiofrequency ablation of tumors to control hypoglycemia
- Unresectable tumors
- Octreotide administration
- Continous glucose monitoring
- Radiofrequecy ablation
- Embolization
- Intra-arterial chemotherapy
References
- ↑ 1.0 1.1 1.2 Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y; et al. (2013). "Diagnosis and management of insulinoma". World J Gastroenterol. 19 (6): 829–37. doi:10.3748/wjg.v19.i6.829. PMC 3574879. PMID 23430217.
- ↑ 2.0 2.1 2.2 Inulinoma. national library of medicine. https://www.nlm.nih.gov/medlineplus/ency/article/000387.htm